Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Propanc Biopharma Inc PPCB

Healthcare Biotechnology
Propanc Biopharma, Inc. is an Australia-based clinical biopharmaceutical company. The Company is focused on the development of novel cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. The Company has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from... see more

Recent & Breaking News (OTCPK:PPCB)

Propanc Confirms PRP Response to Broad Range of Cancer Indications; Sets Date for Scientific Advice Meeting with UK Regulators

PR Newswire March 2, 2016

Past Winner Spotlight: ENDV, PPCH, EYES, LPCN, GALE

Accesswire February 29, 2016

Propanc Discovers PRP Dramatically Suppresses Cancer Stem Cells

PR Newswire February 4, 2016

Where Investors Are Going -- Complementary Research on Sierra Resource Group, Propanc Health Group, US Highland and Linc Energy

Accesswire January 19, 2016

Propanc Receives Additional $525,000 from Institutional Investor; Initiates Animal Safety Toxicology Studies for PRP

PR Newswire January 13, 2016

The Only Bit of "Good News" From 2015

Accesswire December 14, 2015

IPOs & Transactions Week in Review: November 23 - 27

PR Newswire November 30, 2015

Propanc Receives Additional $700,000 After Successful Completion of Animal Efficacy Studies

Accesswire November 30, 2015

SeeThruEquity Issues Update on Propanc Health Group Highlighting Positive Pre-Clinical Study Results

Accesswire November 24, 2015

SeeThruEquity Issues Update on Propanc Health Group Highlighting Positive Pre-Clinical Study Results

Accesswire November 24, 2015

Propanc Secures $4M Financing to Complete Preclinical Animal Studies and Progress Company into Human Trials

Accesswire November 10, 2015

Propanc Secures $4M Financing to Complete Preclinical Animal Studies and Progress Company into Human Trials

Accesswire November 10, 2015

Biotech Bonanza: 4 Stocks With Pending Clinical or Preclinical News (And Why the Results Will Move the Stocks)

Accesswire November 2, 2015

Propanc Selected by OTC Markets Group to Join the OTCQB Venture Index

Accesswire October 26, 2015

Propanc Selected by OTC Markets Group to Join the OTCQB Venture Index

Accesswire October 26, 2015

Propanc Secures Financing to Complete Preclinical Animal Studies and Progress Company towards Human Trials; Updates on Progress and Plans

Accesswire October 1, 2015

Propanc Secures Financing to Complete Preclinical Animal Studies and Progress Company towards Human Trials; Updates on Progress and Plans

Accesswire October 1, 2015

Why Smart Traders Bought the Hillary Clinton Biotech Stock Dip, and Which Stocks They Are Placing Their Bets On

Accesswire September 28, 2015

Propanc Receives Patent Approval in Key Jurisdiction

Accesswire August 31, 2015

Propanc Receives Patent Approval in Key Jurisdiction

Accesswire August 31, 2015